3B Blackbio Dx Limited share price
NSE: 3BBLACKBIO · ISIN INE994E01018
Key numbers
- Market cap
- -
- Current price
- ₹ 1,456.20
- 52-week high / low
- ₹ 1,589 / 1,100
- Stock P/E
- 21.9
- Book value
- ₹ 388.4
- Dividend yield
- 0.34%
- ROCE
- 25.8%
- ROE
- 20.2%
- Debt to equity
- 0.01
- Sales growth (3 yrs)
- 31.9%
- Profit growth (3 yrs)
- 32.2%
- 1-year return
- -
About 3B Blackbio Dx Limited
3B Blackbio Dx Limited engages in the design, development, manufacturing, and commercialization of molecular diagnostic solutions for infectious diseases, oncology, human genetics and antimicrobial resistance in India. The company offers qPCR-based and lateral flow assays rapid tests and Next Gen Sequencing -based molecular diagnostic kits for accurate and reliable testing on patient samples under the TRUPCR, TRUNGS, TRURAPID, brand for testing on patient samples to diagnostics labs. It also offers agrochemical products; technical support and training services. 3B Blackbio Dx Limited was incorporated in 1972 and is headquartered in Bhopal, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 22 | 34 | 50 | 35 | 33 |
| Operating profit | 12 | 15 | 21 | 8 | 9 |
| Net profit | 13 | 15 | 22 | 10 | 10 |
| EPS (₹) | 14.67 | 17.55 | 25.32 | 11.44 | 11.11 |
Peers in Biotechnology
Data for information only, not investment advice. Prices end of day.